Sheraz Ali

464 total citations
38 papers, 305 citations indexed

About

Sheraz Ali is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Emergency Medical Services. According to data from OpenAlex, Sheraz Ali has authored 38 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Geriatrics and Gerontology, 11 papers in Economics and Econometrics and 10 papers in Emergency Medical Services. Recurrent topics in Sheraz Ali's work include Pharmaceutical Practices and Patient Outcomes (18 papers), Patient Safety and Medication Errors (10 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Sheraz Ali is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (18 papers), Patient Safety and Medication Errors (10 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Sheraz Ali collaborates with scholars based in Saudi Arabia, Australia and Pakistan. Sheraz Ali's co-authors include Oluwaseun Egunsola, Mohammed S. Salahudeen, Lre Bereznicki, Gregory M. Peterson, Colin Curtain, Syed Shahzad Hasan, Edward B. De Vol, Amjad Ali, Muhammad Sajjad and Sulaiman Alshammari and has published in prestigious journals such as Frontiers in Pharmacology, British Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

Sheraz Ali

35 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheraz Ali Saudi Arabia 10 144 65 60 59 48 38 305
Elsy Ramia Lebanon 10 147 1.0× 40 0.6× 43 0.7× 43 0.7× 51 1.1× 17 293
Yvonne Hopf Germany 10 143 1.0× 45 0.7× 48 0.8× 48 0.8× 25 0.5× 20 319
Abdullah Al Hamid United Kingdom 12 182 1.3× 63 1.0× 62 1.0× 98 1.7× 35 0.7× 28 474
Hassan Torkamandi Iran 12 164 1.1× 57 0.9× 48 0.8× 63 1.1× 51 1.1× 26 377
Linda Aagaard Thomsen Denmark 7 239 1.7× 116 1.8× 72 1.2× 67 1.1× 35 0.7× 13 376
Peter Vanbrabant Belgium 9 196 1.4× 131 2.0× 36 0.6× 33 0.6× 28 0.6× 38 391
Lisa Harinstein United States 11 124 0.9× 83 1.3× 20 0.3× 47 0.8× 52 1.1× 20 356
Nazanin Falconer Australia 9 177 1.2× 90 1.4× 64 1.1× 46 0.8× 12 0.3× 29 256
Annemieke Floor‐Schreudering Netherlands 13 170 1.2× 33 0.5× 62 1.0× 27 0.5× 58 1.2× 24 362
Lina Naseralallah Qatar 10 155 1.1× 95 1.5× 24 0.4× 18 0.3× 48 1.0× 31 267

Countries citing papers authored by Sheraz Ali

Since Specialization
Citations

This map shows the geographic impact of Sheraz Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheraz Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheraz Ali more than expected).

Fields of papers citing papers by Sheraz Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheraz Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheraz Ali. The network helps show where Sheraz Ali may publish in the future.

Co-authorship network of co-authors of Sheraz Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Sheraz Ali. A scholar is included among the top collaborators of Sheraz Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheraz Ali. Sheraz Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alotaibi, Saud S., et al.. (2024). Impact of telepharmacy during COVID-19 on patients’ outcome during COVID-19: a systematic literature review. Pharmacy Practice. 21(4). 1–8. 3 indexed citations
3.
Ali, Sheraz, et al.. (2024). Adverse Drug Event–Related Hospital Admissions among Australian Aged Care Residents: A Cross-Sectional Study. Journal of the American Medical Directors Association. 25(7). 105041–105041. 1 indexed citations
4.
Ali, Sheraz, Colin Curtain, Gregory M. Peterson, & Mohammed S. Salahudeen. (2023). Exploring Australian pharmacists’ perceptions and practices towards reducing the risk of medicines-related harm in aged care residents. Frontiers in Pharmacology. 14. 1131456–1131456. 2 indexed citations
5.
Ali, Sheraz, Colin Curtain, Gregory M. Peterson, & Mohammed S. Salahudeen. (2023). Exploring Australian pharmacists' views toward reducing the risk of medicines‐related harm in aged care residents. Pharmacology Research & Perspectives. 11(3). e01104–e01104. 1 indexed citations
6.
Ali, Sheraz, et al.. (2022). Hospital pharmacists’ awareness and perspective toward the management of COVID-19 pandemic in the Kingdom of Saudi Arabia. Pharmacy Practice. 20(3). 1–7. 1 indexed citations
7.
Alshammari, Sulaiman, et al.. (2021). Knowledge of Anticoagulation Among Saudi Patients With Atrial Fibrillation: A Cross-Sectional Study. Cureus. 13(11). e19237–e19237. 6 indexed citations
8.
Ali, Sheraz, et al.. (2021). Prescription Pattern of Empirical Antibiotic Therapy in the Burn Unit of a Tertiary Care Setting in the Kingdom of Saudi Arabia. Journal of Pharmacy And Bioallied Sciences. 13(2). 188–192. 2 indexed citations
9.
Alshammari, Sulaiman, et al.. (2021). Quality of Life and Awareness of Hypertension Among Hypertensive Patients in Saudi Arabia. Cureus. 13(5). e14879–e14879. 14 indexed citations
10.
Egunsola, Oluwaseun, et al.. (2021). Medication Misadventures Among COVID-19 Patients in Saudi Arabia. Cureus. 13(6). e15513–e15513. 9 indexed citations
11.
Ali, Sheraz, et al.. (2021). Patient Benefit of Clinical Research in Diversely Advanced African Developing Countries. Current Therapeutic Research. 96. 100656–100656. 2 indexed citations
12.
Alhifany, Abdullah A., et al.. (2021). Prescribing errors among adult patients in a large tertiary care system in Saudi Arabia. Annals of Saudi Medicine. 41(3). 147–156. 6 indexed citations
13.
Ali, Sheraz, et al.. (2020). Categorizing and understanding medication errors in hospital pharmacy in relation to human factors. Saudi Pharmaceutical Journal. 28(12). 1674–1685. 9 indexed citations
14.
Ali, Sheraz, Gregory M. Peterson, Lre Bereznicki, & Mohammed S. Salahudeen. (2019). Association between anticholinergic drug burden and mortality in older people: a systematic review. European Journal of Clinical Pharmacology. 76(3). 319–335. 32 indexed citations
15.
Ali, Sheraz, et al.. (2019). Information seeking behavior and awareness among physicians regarding drug information centers in Saudi Arabia. Pharmacy Practice. 17(2). 1498–1498. 9 indexed citations
16.
Ali, Sheraz, et al.. (2018). Knowledge and attitude of health-care professionals toward adverse drug reactions reporting at King Saud Medical City. Journal of Pharmacy And Bioallied Sciences. 10(1). 29–29. 15 indexed citations
17.
Ali, Sheraz, et al.. (2017). Assessment of queries received by the drug information center at King Saud Medical City. Journal of Pharmacy And Bioallied Sciences. 9(4). 246–246. 11 indexed citations
18.
Ali, Sheraz, et al.. (2017). Magnitude and characteristics of clinical trials in the Kingdom of Saudi Arabia: A cross-sectional analysis. Contemporary Clinical Trials Communications. 7. 126–129. 7 indexed citations
19.
Ali, Sheraz, et al.. (2017). Analysis of medication errors at a large tertiary care hospital in Saudi Arabia: a retrospective analysis. International Journal of Clinical Pharmacy. 39(5). 1004–1007. 29 indexed citations
20.
Ali, Sheraz, et al.. (2015). Improving environmental cleaning process in hemodialysis unit at King Saud Medical City. Antimicrobial Resistance and Infection Control. 4(S1).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elsy Ramia Breakdown of academic impact, for papers by Yvonne Hopf Breakdown of academic impact, for papers by Abdullah Al Hamid Breakdown of academic impact, for papers by Hassan Torkamandi Breakdown of academic impact, for papers by Linda Aagaard Thomsen Breakdown of academic impact, for papers by Peter Vanbrabant Breakdown of academic impact, for papers by Lisa Harinstein Breakdown of academic impact, for papers by Nazanin Falconer Breakdown of academic impact, for papers by Annemieke Floor‐Schreudering Breakdown of academic impact, for papers by Lina Naseralallah
Rankless by CCL
2026